Evidence-based Recommendations For Interpregnancy Intervals In High-income Countries
Funder
National Health and Medical Research Council
Funding Amount
$423,305.00
Summary
This study will identify the optimal and harmful interpregnancy intervals for a range of maternal and child outcomes in three high-income countries. With a study population of more than 7.5 million births and a longitudinal study design that matches pregnancies to the same women, this study will inform new interpregnancy interval recommendations for high-income countries that will lead to a reduction in avoidable excess morbidities attributable to uninformed pregnancy planning.
Improving Antiretroviral Treatment (ART) Initiation For People Living With HIV In Australia: A Realistic And Feasible Approach?
Funder
National Health and Medical Research Council
Funding Amount
$434,722.00
Summary
Antiretroviral treatment (ART) has improved the lives of people living with HIV (PLHIV). This study will investigate barriers, incentives and reasons that influence decision making of PLHIV and clinicians regarding whether to start ART and when. The study will examine the potential public health impact of promoting ART use on the HIV epidemic. The study will make significant contributions to improvement of ART use and advances in HIV prevention.
A Randomised Controlled Trial Of Daily Antibacterial Mouthwash To Reduce Pharyngeal Gonorrhoea Among Men Who Have Sex With Men (MSM)
Funder
National Health and Medical Research Council
Funding Amount
$376,730.00
Summary
Gonorrhoea is a common sexually transmitted infection (STI) among gay men, and the throat is the commonest site of infection. There is early data to suggest Listerine mouthwash can be used to prevent gonorrhoea. Our study will examine whether men use Listerine every day will reduce the risk of gonorrhoea in the throat compared those who use another mouthwash product which does not have an effect on gonorrhoea.
A Community-based Cluster Randomized Controlled Trial In Rural Bangladesh To Evaluate The Impact Of The Use Of Iron/folic Acid Supplements Early In Pregnancy On The Risk Of Neonatal MortalityBACKGROUND An Effective Program Of Antenatal Iron/folic Ac
Funder
National Health and Medical Research Council
Funding Amount
$2,564,922.00
Summary
This community-based trial in rural Bangladesh will determine if iron/folic acid supplementation commencing in the first trimester of pregnancy significantly reduces newborn deaths, and whether this approach is cost-effective. This trial has the potential to inform international public health policy about the importance of starting antenatal iron/folic acid supplementation early to improve neonatal survival, and to help countries reach their child survival Millennium Development Goal